Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's stake in cardiovascular care. Shares of North Chicago, Illinois-based Abbott plunged, while St.
MINYANVILLE ORIGINAL Twenty-four hours after Vikram Pandit was unceremoniously squeezed out at Citigroup (C), Indra Nooyi did little to redeem the reputation of Indian CEOs, with PepsiCo (PEP) ending down in an up market after …
St. Jude will visit the Nasdaq MarketSite in Times Square along with Kmart, a mass merchandising company and …
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of …
Chicago-headquartered Abbott announced Thursday it is acquiring Minnesota-based St. Jude Medical in a cash-and-stock deal worth about $25 billion. The acquisition, subject to regulatory approvals, will strengthen Abbott's position in the …
The lawsuit filed today alleges that Muddy Waters, MedSec and the other defendants intentionally disseminated false …
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's stake in cardiovascular care. Shares of North Chicago, Illinois-based Abbott plunged, while …
The Food and Drug Administration is investigating the claims by Muddy Waters and research firm MedSec Holdings Inc. St. Jude has denied the allegations and sued both firms, saying they disseminated false information to manipulate its …
What: St. Jude Children's Research Hospital® is leading the way the world understands, treats and defeats childhood …